Vanguard Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Sell |
364,077
-843,998
| -70% | -$506K | ﹤0.01% | 4076 |
|
|
2025
Q1 | $326K | Sell |
1,208,075
-48,630
| -4% | -$13.1K | ﹤0.01% | 3980 |
|
|
2024
Q4 | $653K | Hold |
1,256,705
| – | – | ﹤0.01% | 3873 |
|
|
2024
Q3 | $4.07M | Hold |
1,256,705
| – | – | ﹤0.01% | 3345 |
|
|
2024
Q2 | $3.77M | Hold |
1,256,705
| – | – | ﹤0.01% | 3371 |
|
|
2024
Q1 | $5.84M | Sell |
1,256,705
-54,100
| -4% | -$252K | ﹤0.01% | 3240 |
|
|
2023
Q4 | $5.43M | Buy |
1,310,805
+770
| +0.1% | +$3.19K | ﹤0.01% | 3255 |
|
|
2023
Q3 | $3.93M | Hold |
1,310,035
| – | – | ﹤0.01% | 3347 |
|
|
2023
Q2 | $3.22M | Sell |
1,310,035
-194,944
| -13% | -$480K | ﹤0.01% | 3492 |
|
|
2023
Q1 | $3.4M | Sell |
1,504,979
-12,001
| -0.8% | -$27.1K | ﹤0.01% | 3484 |
|
|
2022
Q4 | $5.29M | Buy |
1,516,980
+73,020
| +5% | +$255K | ﹤0.01% | 3274 |
|
|
2022
Q3 | $53.5M | Buy |
1,443,960
+20,928
| +1% | +$775K | ﹤0.01% | 2149 |
|
|
2022
Q2 | $27M | Buy |
1,423,032
+99,018
| +7% | +$1.88M | ﹤0.01% | 2496 |
|
|
2022
Q1 | $35.7M | Buy |
1,324,014
+99,113
| +8% | +$2.68M | ﹤0.01% | 2471 |
|
|
2021
Q4 | $27.6M | Buy |
1,224,901
+310,178
| +34% | +$6.99M | ﹤0.01% | 2667 |
|
|
2021
Q3 | $24M | Buy |
914,723
+142,947
| +19% | +$3.75M | ﹤0.01% | 2756 |
|
|
2021
Q2 | $24.7M | Buy |
771,776
+78,469
| +11% | +$2.51M | ﹤0.01% | 2741 |
|
|
2021
Q1 | $24.4M | Buy |
693,307
+30,684
| +5% | +$1.08M | ﹤0.01% | 2678 |
|
|
2020
Q4 | $21.3M | Sell |
662,623
-10,158
| -2% | -$326K | ﹤0.01% | 2603 |
|
|
2020
Q3 | $25.3M | Sell |
672,781
-18,871
| -3% | -$710K | ﹤0.01% | 2335 |
|
|
2020
Q2 | $31M | Buy |
691,652
+111,794
| +19% | +$5M | ﹤0.01% | 2224 |
|
|
2020
Q1 | $19.8M | Buy |
579,858
+10,105
| +2% | +$345K | ﹤0.01% | 2289 |
|
|
2019
Q4 | $22.2M | Buy |
+569,753
| New | +$22.2M | ﹤0.01% | 2485 |
|